{"filing":{"accession_number":"0001628280-26-042932","cik":"0001830214","ticker":"DNABW","company_name":"Ginkgo Bioworks Holdings, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"dna-20260611.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/dna-20260611.htm"},"events":[{"id":10338,"run_id":9067,"accession_number":"0001628280-26-042932","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of Ginkgo Bioworks' 2026 annual meeting of shareholders held on June 11, 2026. The filing presents detailed voting results for three proposals: election of six directors (with separate voting by Class A and Class B shareholders), ratification of Deloitte \u0026 Touche LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they determine board composition and affirm key governance decisions.","company_name":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNABW","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":6630,"accession_number":"0001628280-26-042932","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Ginkgo Bioworks' 2026 annual meeting of shareholders held on June 11, 2026. The filing presents detailed voting results for three proposals: election of six directors (with separate voting by Class A and Class B shareholders), ratification of Deloitte \u0026 Touche LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they determine board composition and affirm key governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:03:56.203313+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6630,"accession_number":"0001628280-26-042932","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Ginkgo Bioworks' 2026 annual meeting of shareholders held on June 11, 2026. The filing presents detailed voting results for three proposals: election of six directors (with separate voting by Class A and Class B shareholders), ratification of Deloitte \u0026 Touche LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they determine board composition and affirm key governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:03:56.203313+00:00","company_name":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNABW","filing_date":"2026-06-12"}]}